The Food and Drug Administration said Monday it planned to beef up oversight of the sprawling, $50-billion-a-year dietary supplements industry, warning that the sector’s explosive growth has resulted in risks to consumers — more supplements “spiked” with unlisted drug ingredients, and false and misleading claims about health benefits.
You can read more about it from NY Times or Washington Post by clicking on their names.